BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14962977)

  • 1. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.
    Ruan Q; Lesort M; MacDonald ME; Johnson GV
    Hum Mol Genet; 2004 Apr; 13(7):669-81. PubMed ID: 14962977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.
    Mao Z; Choo YS; Lesort M
    Eur J Neurosci; 2006 Apr; 23(7):1701-10. PubMed ID: 16623826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
    Ruan Q; Quintanilla RA; Johnson GV
    J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin.
    Okada N; Yako T; Nakamura S; Shimazawa M; Hara H
    J Pharmacol Sci; 2021 Dec; 147(4):367-375. PubMed ID: 34663519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
    Choo YS; Johnson GV; MacDonald M; Detloff PJ; Lesort M
    Hum Mol Genet; 2004 Jul; 13(14):1407-20. PubMed ID: 15163634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
    Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
    J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins.
    Ruiz C; Casarejos MJ; Rubio I; Gines S; Puigdellivol M; Alberch J; Mena MA; de Yebenes JG
    Brain Res; 2012 Jun; 1459():100-12. PubMed ID: 22560595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.
    Milakovic T; Johnson GV
    J Biol Chem; 2005 Sep; 280(35):30773-82. PubMed ID: 15983033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
    Quintanilla RA; Jin YN; von Bernhardi R; Johnson GV
    Mol Neurodegener; 2013 Dec; 8():45. PubMed ID: 24330821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hMTH1 expression protects mitochondria from Huntington's disease-like impairment.
    Ventura I; Russo MT; De Nuccio C; De Luca G; Degan P; Bernardo A; Visentin S; Minghetti L; Bignami M
    Neurobiol Dis; 2013 Jan; 49(12):148-58. PubMed ID: 22974734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats.
    Gellerich FN; Gizatullina Z; Nguyen HP; Trumbeckaite S; Vielhaber S; Seppet E; Zierz S; Landwehrmeyer B; Riess O; von Hörsten S; Striggow F
    J Biol Chem; 2008 Nov; 283(45):30715-24. PubMed ID: 18606820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism.
    Lee JM; Ivanova EV; Seong IS; Cashorali T; Kohane I; Gusella JF; MacDonald ME
    PLoS Genet; 2007 Aug; 3(8):e135. PubMed ID: 17708681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition.
    Maciel EN; Kowaltowski AJ; Schwalm FD; Rodrigues JM; Souza DO; Vercesi AE; Wajner M; Castilho RF
    J Neurochem; 2004 Sep; 90(5):1025-35. PubMed ID: 15312158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.
    Milakovic T; Quintanilla RA; Johnson GV
    J Biol Chem; 2006 Nov; 281(46):34785-95. PubMed ID: 16973623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
    Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
    J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.